➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Mallinckrodt
Baxter
Medtronic
Moodys

Last Updated: February 25, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Lidocaine Hydrochloride Preservative Free

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00468429 Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery Unknown status Grewal Eye Institute Phase 4 2007-05-01 This study analyzes the safety and efficacy of off-label Subconjunctival Injection of bevacizumab (Avastin) versus 0.02% mitomycin C (MMC) for preventing bleb failure following glaucoma filtration surgery.
NCT00948103 The Interest of the Nitrous Oxide During Intravesical Injection of Botulinum Toxin A Completed Assistance Publique - Hôpitaux de Paris Phase 3 2008-09-01 Second line treatment for detrusor hyperreflexia is the intravesical BTX-A injections. First 300 units Botox are diluted with 30 ml of preservative-free saline. Using a rigid cystoscope and an injection needle, BTX-A is injected into 30 sites within the detrusor muscle. The used of KALINOX® (50% nitrous oxide and oxygen) inhalation has demonstrated analgesic efficacy in various procedures (obstetric, liver biopsy, transrectal ultrasound guided prostate biopsy, emergency) The aim of this study is to investigate the safety and efficacy of analgesia with N2O/O2 inhalation for detrusor BTX-A injections using a rigid cystoscope.
NCT01905137 Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain Recruiting Allergan N/A 2013-07-01 The purpose of this study is to determine whether there is a change in patient-reported pelvic pain following pelvic floor injections of 200 units of Botox compared with 20cc of normal saline.
NCT01905137 Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain Recruiting Boston Urogynecology Associates N/A 2013-07-01 The purpose of this study is to determine whether there is a change in patient-reported pelvic pain following pelvic floor injections of 200 units of Botox compared with 20cc of normal saline.
NCT02196441 Evaluation of Deep Topical Fornix Nerve Block Versus Topical Anaesthesia Procedure Unknown status Cairo University N/A 2014-08-01 General anaesthesia now a days is not the first choice in phakic intra ocular lens surgery (Phakic IOL) , the short duration of the surgery, general anaesthesia complications, decrease the length of hospital stay and decreasing the costs direct the interest to the regional anaesthesia By the time the traditional retro and peribulbar injections recede to a newer techniques that is safer and cheaper, sub tenon's block using a blunt needle took over due to the more safety profile Even though, still serious problems can occur specially in patients with long axial length. Deep topical fornix nerve block anaesthesia (DTFNB) and topical anaesthesia gradually took over with promising and successful results, decreasing length of hospital stay and increasing patient satisfaction and fewer margins of complications. In this study the investigators compared topical anaesthesia alone with DTFNBA in patients undergoing posterior chamber phakic IOL surgery (Visian ICL).
NCT02413268 Topical Nitroglycerin To Prevent Radial Artery Occlusion After Transradial Access: NTP-RAO Trial Not yet recruiting Total Cardiovascular Solutions Phase 3 2015-06-01 A randomized comparison of topical nitroglycerin versus placebo gel for prevention of radial artery occlusion after transradial catheterization.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lidocaine Hydrochloride Preservative Free

Condition Name

Condition Name for Lidocaine Hydrochloride Preservative Free
Intervention Trials
Pain 2
Video Assisted Thoracic Surgery 1
Injection Site Vesicles 1
Osteoarthritis, Knee 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Lidocaine Hydrochloride Preservative Free
Intervention Trials
Dry Eye Syndromes 1
Hypotension 1
Cataract 1
Peripheral Nervous System Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Lidocaine Hydrochloride Preservative Free

Trials by Country

Trials by Country for Lidocaine Hydrochloride Preservative Free
Location Trials
United States 6
France 1
Egypt 1
India 1
Saudi Arabia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Lidocaine Hydrochloride Preservative Free
Location Trials
California 3
Illinois 1
Pennsylvania 1
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Lidocaine Hydrochloride Preservative Free

Clinical Trial Phase

Clinical Trial Phase for Lidocaine Hydrochloride Preservative Free
Clinical Trial Phase Trials
Phase 4 4
Phase 3 2
Phase 2 1
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Lidocaine Hydrochloride Preservative Free
Clinical Trial Phase Trials
Not yet recruiting 8
Recruiting 3
Unknown status 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Lidocaine Hydrochloride Preservative Free

Sponsor Name

Sponsor Name for Lidocaine Hydrochloride Preservative Free
Sponsor Trials
Total Cardiovascular Solutions 1
Fayoum University Hospital 1
Cairo University 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Lidocaine Hydrochloride Preservative Free
Sponsor Trials
Other 15
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Harvard Business School
McKinsey
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.